FilingReader Intelligence

Boya Bio-Pharmaceutical sells 80% stake for 158m yuan

July 22, 2025 at 05:26 AM UTC•By FilingReader AI

Boya Bio-Pharmaceutical Group sold its 80% stake in Jiangxi Boya Xinhe Pharmaceutical to Fuzhou High-tech Zone Financial Investment Group for RMB 158,165,500 via public listing.

Following the sale, Boya Bio-Pharmaceutical retains 10.7% equity directly and 9.3% through a subsidiary. Jiangxi Boya Xinhe will no longer be consolidated into the company's financial statements.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

Primary Source Document

Company announcement regarding the progress and transaction results of the public listing and transfer of 80% equity in Jiangxi Boya Xinhe Pharmaceutical Company LimitedJuly 21, 2025 at 12:54 AM UTC

Boya Bio-Pharmaceutical Group

SZSE:300294•Shenzhen Stock Exchange

Pharmaceuticals

RSS feed for Boya Bio-Pharmaceutical Group

News Alerts

Get instant email alerts when Boya Bio-Pharmaceutical Group publishes news

Free account required • Unsubscribe anytime

Browse RSS Feeds

Filing Activity Timeline

View Complete Filing History →